Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Immune System Diseases × Cytarabine × 1 year × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 115 Precursor Cell Lymphoblastic Leukemia-Lymphoma 47 Myelodysplastic Syndromes 25 Leukemia 25 Burkitt Lymphoma 23 Leukemia, Biphenotypic, Acute 17 Recurrence 14 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 13 Lymphoma, Mantle-Cell 12 Leukemia, Myelomonocytic, Chronic 10 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 8 Myeloproliferative Disorders 8 Lymphoma, Non-Hodgkin 8 Lymphoma 8 Sarcoma, Myeloid 5 Neoplasm, Residual 5 Lymphoma, Large B-Cell, Diffuse 5 Leukemia, Monocytic, Acute 5 Leukemia, Myelomonocytic, Acute 4 Hodgkin Disease 4 Hematologic Neoplasms 4 Lymphoma, Follicular 3 Down Syndrome 3 Blast Crisis 3 Multiple Myeloma 2 Lymphoma, B-Cell 2 Leukemia, Myelomonocytic, Juvenile 2 Leukemia, Myeloid, Accelerated Phase 2 Leukemia, Myeloid 2 Leukemia, Megakaryoblastic, Acute 2

Interventions

fludarabine 7 Cyclophosphamide 6 fludarabine phosphate 4 Whole-Body Irradiation 2 Tacrolimus 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Mycophenolic Acid 2 Mesna 2 Melphalan 2 Busulfan 2 Bendamustine Hydrochloride 2 AP 1903 reagent 2 pimonidazole 1 ibrutinib 1 enzalutamide 1 Surveys and Questionnaires 1 CA-4948 1 Bone Marrow Transplantation 1 ARQ531 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡